Advanta Medical Solutions LLC

Health information and revenue cycle services company.

Based in MD

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $40K in lobbying spend across 3 quarterly filings, Advanta Medical Solutions LLC is an active lobbying client. Their lobbying covers 1 issue area.

$40K
Total Spend
1
Years Active
1
Firms Hired
2
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$40K

Issues Lobbied

Medicare/Medicaid

Lobbying Firms

Barnes & Thornburg, LLP

Lobbyists

Robert GrandDavid Paragas

Government Agencies Targeted

These are the government entities that Advanta Medical Solutions LLC disclosed contacting in their lobbying filings.

Centers For Medicare and Medicaid Services (CMS)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid

Quality improvement organization contract and services.

Assist client with Quality Improvement Organization status.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

The American Occupational Therapy Association, INC. (Aota)
$6.0M total spend
Plasma Protein Therapeutics Association
$4.8M total spend
Digestive Health Physicians Association, INC.
$2.0M total spend
American Society of Addiction Medicine
$1.9M total spend
Association for Molecular Pathology
$1.5M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.